Page last updated: 2024-12-07
4-phosphonomethylphenylalanine
Description
4-(phosphonomethyl)-L-phenylalanine : A 4-(phosphonomethyl)phenylalanine that has L-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
4-(phosphonomethyl)phenylalanine : A phenylalanine derivative that is phenylalanine substituted by a phosphonomethyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 126687 |
SCHEMBL ID | 738555 |
MeSH ID | M0223263 |
Synonyms (31)
Synonym |
4-(phosphonomethyl)phenylalanine |
2-amino-3-(4-phosphonomethyl-phenyl)-propionic acid |
4-phosphonomethylphenylalanine |
(2s)-2-amino-3-[4-(phosphonomethyl)phenyl]propanoic acid |
142434-81-9 |
4-phosphonomethyl-l-phe |
p-(phosphonomethyl)phenylalanine |
l-phenylalanine, 4-(phosphonomethyl)- |
4-phosphonomethyl-l-phenylalanine |
114791-27-4 |
SCHEMBL738555 |
AM83477 |
4-phosphonomethyl-l-phenylalanine (h-l-phe(4-ch2po3h2)-oh) |
mfcd03701454 |
AKOS027383595 |
J-007649 |
4-phosphomethyl-l-phenylalanine |
4-phosphonomethyl-phenylalanine |
4-(phosphonomethyl)-l-phenylalanine |
142434-80-8 |
Q27464477 |
DTXSID20931448 |
AC1165 |
(s)-2-amino-3-[4-(phosphonomethyl)phenyl]propanoic acid |
(s)-2-amino-3-(4-(phosphonomethyl)phenyl)propanoic acid |
A920917 |
(s)-2-amino-3-(4-(phosphonomethyl)phenyl)propanoicacid |
l-pmp-oh |
2-amino-3-[4-(phosphonomethyl)phenyl] propanoic acid |
l-4-(phosphonomethyl)-phe-oh |
d-4-(phosphonomethyl)-phe-oh |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.02 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.21 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |